Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-18-003155

Chief Medical Officer acquired 14,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Berger Mark Stanley Chief Medical Officer 2018-03-06 Other acquisition +14,000 $0.50 $7,000 19,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Berger Mark Stanley Chief Medical Officer 2018-03-06 Other acquisition · Series A Warrants +3,500 $0.50 $1,750 3,500 D: show line 2 in the form
Berger Mark Stanley Chief Medical Officer 2018-03-06 Other acquisition · Series B Warrants +10,500 $0.50 $5,250 10,500 D: show line 3 in the form
Loading xslF345X03/f4030618berger_actinium.xml…